SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: phoenix_rising who wrote (1819)4/6/2016 1:48:30 AM
From: mokelumne river  Read Replies (1) of 2026
 
Yep. That means it is back to Allergan making the decision as to whether to market Vitaros if the FDA approves. I thought it would be more interesting with Pfizer making that decision as Pfizer is the company that kicked off the PDE5 revolution as the patent holder and then marketer for Viagra. The FDA approved Viagra for ED in 1998.

It is pretty clear that FDA approval of Vitaros would be a game changer for Apricus, regardless of Allergan's decision. But as we all know, approval is not a sure thing.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News